MacuLogix locks in $38.7 mln Series D
Pennsylvania-based MacuLogix, a medical device company in the optometry and ophthalmology industry, has secured $38.7 million in Series D round of financing. Vivo Capital led the round with participation from return backers Fisk Ventures, Roche Venture Fund, Berwind Private Equity and Life Sciences Greenhouse of Central Pennsylvania.
4 March 2019•1 min read
